Repository logo
 
Publication

A pilot study on the usefulness of peripheral blood flow cytometry for the diagnosis of lower risk myelodysplastic syndromes: the "MDS thermometer"

dc.contributor.authorAires, A.
dc.contributor.authorTeixeira, M.
dc.contributor.authorLau, C.
dc.contributor.authorMoreira, C.
dc.contributor.authorSpínola, A.
dc.contributor.authorMota, A.
dc.contributor.authorFreitas, I.
dc.contributor.authorCoutinho, J.
dc.contributor.authorLima, M.
dc.date.accessioned2019-07-18T09:08:56Z
dc.date.available2019-07-18T09:08:56Z
dc.date.issued2018-03-13
dc.description.abstractBackground: Immunophenotypic analysis of the bone marrow (BM) cells has proven to be helpful in the diagnosis of Myelodysplastic Syndromes (MDS). However, the usefulness of flow cytometry (FCM) for the detection of myelodysplasia in the peripheral blood (PB) still needs to be investigated. The aim of this pilot study was to evaluate the value of FCM-based PB neutrophil and monocyte immunophenotyping for the diagnosis of lower risk MDS (LR-MDS). Methods: We evaluated by 8-color FCM the expression of multiple cell surface molecules (CD10, CD11b, CD11c, CD13, CD14, CD15, CD16, CD34, CD45, CD56, CD64 and HLA-DR) in PB neutrophils and monocytes from a series of 14 adult LR-MDS patients versus 14 normal individuals. Results: Peripheral blood neutrophils from patients with LR-MDS frequently had low forward scatter (FSC) and side scatter (SSC) values and low levels of CD11b, CD11c, CD10, CD16, CD13 and CD45 expression, in that order, as compared to normal neutrophils. In addition, patients with LR-MDS commonly display a higher fraction of CD14+CD56+ and a lower fraction of CD14+CD16+ monocytes in the PB. Based on these results, we proposed an immunophenotyping score based on which PB samples from patients with LR-MDS could be distinguished from normal PB samples with a sensitivity 93% and a specificity of 100%. In addition, we used this score to construct the MDS Thermometer, a screening tool for detection and monitoring of MDS in the PB in clinical practice. Conclusions: Peripheral blood neutrophil and monocyte immunophenotyping provide useful information for the diagnosis of LR-MDS, as a complement to cytomorphology. If validated by subsequent studies in larger series of MDS patients and extended to non-MDS patients with cytopenias, our findings may improve the diagnostic assessment and avoid invasive procedures in selected groups of MDS patients.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBMC Hematol. 2018 Mar 13;18:6pt_PT
dc.identifier.doi10.1186/s12878-018-0101-8pt_PT
dc.identifier.issn2052-1839
dc.identifier.urihttp://hdl.handle.net/10400.16/2270
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherBMCpt_PT
dc.relation.publisherversionhttps://bmchematol.biomedcentral.com/articles/10.1186/s12878-018-0101-8pt_PT
dc.subjectFlow cytometrypt_PT
dc.subjectLower risk MDSpt_PT
dc.subjectMyelodysplastic syndromespt_PT
dc.subjectPeripheral bloodpt_PT
dc.titleA pilot study on the usefulness of peripheral blood flow cytometry for the diagnosis of lower risk myelodysplastic syndromes: the "MDS thermometer"pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceEnglandpt_PT
oaire.citation.issue1pt_PT
oaire.citation.startPage6pt_PT
oaire.citation.titleBMC Hematologypt_PT
oaire.citation.volume18pt_PT
person.familyNameLima
person.givenNameMargarida
person.identifier.ciencia-id8410-F6C9-183F
person.identifier.orcid0000-0001-9702-5260
person.identifier.ridS-7466-2016
person.identifier.scopus-author-id7202143317
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication1559a9cf-10eb-4d08-b39b-b58079d3bf45
relation.isAuthorOfPublication.latestForDiscovery1559a9cf-10eb-4d08-b39b-b58079d3bf45

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
A pilot study on the usefulness.pdf
Size:
2.8 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.35 KB
Format:
Item-specific license agreed upon to submission
Description: